Atrial Fibrillation Devices Market

Atrial fibrillation (also called AFib or AF) is a quivering or irregular heartbeat (arrhythmia) that can lead to blood clots, stroke, heart failure and other heart-related complications. Current treatments span a spectrum of non-invasive to highly invasive options and include medical and surgical variants. The success of the MAZE procedure and its successors has led to the development of surgical ablation devices designed to mark cardiac tissue in a manner similar to suture lines, thereby disrupting the path of the electrical impulses causing the patient?s AF.
Atrial Fibrillation Devices Market contains market size and forecasts of Atrial Fibrillation Devices in global, including the following market information:

• Global Atrial Fibrillation Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Atrial Fibrillation Devices Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Atrial Fibrillation Devices companies in 2021 (%)

The global Atrial Fibrillation Devices market was valued at 2986 million in 2021 and is projected to reach US$ 5926.3 million by 2028, at a CAGR of 10.3% during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Catheter Ablation Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Atrial Fibrillation Devices include Abbott, Boston Scientific, Biosense Webster, Medtronic, Japan Lifeline, AtriCure, Biotronik, Philips and Synaptic Medical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Atrial Fibrillation Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Atrial Fibrillation Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Atrial Fibrillation Devices Market Segment Percentages, by Type, 2021 (%)

• Catheter Ablation
• Maze Surgery

Global Atrial Fibrillation Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Atrial Fibrillation Devices Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Ambulatory Surgical Centers
• Others

Global Atrial Fibrillation Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Atrial Fibrillation Devices Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

To know more about market statistics, Download a FREE Sample copy

The report also provides analysis of leading market participants including:

• Key companies Atrial Fibrillation Devices revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Atrial Fibrillation Devices revenues share in global market, 2021 (%)
• Key companies Atrial Fibrillation Devices sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Atrial Fibrillation Devices sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbott
• Boston Scientific
• Biosense Webster
• Medtronic
• Japan Lifeline
• AtriCure
• Biotronik
• Philips
• Synaptic Medical
• Osypka AG
• MicroPort Scientific
• CardioFocus
• Lepu Medical
• APT Med
• TZ Medical
• Johnson & Johnson